Biotechnology Stocks I Performance Guide: Recursion Pharmaceuticals, Inc. (RXRX)
RXRX has no dividends
Table and Chart of RXRX Performance
See what a $1,000 investment in RXRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RXRX Returns | |
|---|---|
| Start Date | May-28-2021 |
| Start Price | $26.36 |
| End Date | Dec-01-2023 |
| End Price | $7.39 |
| # Prices | 32 |
| Min Date | Apr-28-2023 |
| Min Price | $4.77 |
| Max Date | Jun-30-2021 |
| Max Price | $36.50 |
| Total Return | -71.97% |
| Annualized Return | -37.93% |
| Current Value of $1,000 Purchase | $280 |
| Number Returns | 496 |
| Average Return | -26.76% |
| Number Profitable Returns | 109 |
| Percent Profitable Returns | 21.98% |
| Number Unprofitable Returns | 387 |
| Percent Unprofitable Returns | 78.02% |
| Profitable to Unprofitable Returns Ratio | 0.28 |
| RXRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,595,309,000 | Price to Sales | 33.68 |
| Earnings per Share | $-1.4600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.643 |
| PRICE DATA | |
| 52 Week High | $16.75 |
| 52 Week Low | $4.54 |
| Analyst Target Price | $15.57 |
| 50-Day Moving Average | $6.5 |
| 200-Day Moving Average | $7.87 |
| FINANCIAL DATA | |
| Revenue per Share | $0.238 |
| Revenue | $47,360,000 |
| Profit Margin | 0% |
| Return on Equity | -0.708% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RXRX Compare Returns with S&P 500
RXRX Trendline Chart